NSBCX
Price
$62.82
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
VITSX
Price
$129.67
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

NSBCX vs VITSX

Header iconNSBCX vs VITSX Comparison
Open Charts NSBCX vs VITSXBanner chart's image
Nuveen Dividend Growth C
Price$62.82
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Market Idx I
Price$129.67
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NSBCX vs VITSX Comparison Chart
Loading...
VS
NSBCX vs. VITSX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSBCX is a StrongBuy and VITSX is a Buy.

FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.72T vs. NSBCX (6.55B). VITSX pays higher dividends than NSBCX: VITSX (1.36) vs NSBCX (0.33). NSBCX was incepted earlier than VITSX: NSBCX (18 years) vs VITSX (27 years). NSBCX is a more actively managed with annual turnover of: 17.00 vs. VITSX (2.00). NSBCX has a lower initial minimum investment than VITSX: NSBCX (2500) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 24.07 vs. NSBCX (21.48). VITSX return over 5 years is better than : 82.06 vs. NSBCX (46.78).
NSBCXVITSXNSBCX / VITSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years27 years-
Gain YTD16.48416.87598%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.55B1.72T0%
Annual Yield % from dividends0.331.3624%
Returns for 1 year21.4824.0789%
Returns for 3 years23.2521.32109%
Returns for 5 years46.7882.0657%
Returns for 10 years88.39180.7949%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COLL37.500.97
+2.66%
Collegium Pharmaceutical
VNDA5.100.11
+2.20%
Vanda Pharmaceuticals
TSEM42.850.88
+2.10%
Tower Semiconductor Ltd
MPLX43.780.47
+1.09%
Mplx LP
ELEV0.61N/A
-0.20%
Elevation Oncology